Vigil Neuroscience
VIGL
VIGL was delisted on the 4th of August, 2025.
46 hedge funds and large institutions have $84.4M invested in Vigil Neuroscience in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 6 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
2% more funds holding
Funds holding: 45 → 46 (+1)
1.64% less ownership
Funds ownership: 71.21% → 69.57% (-1.6%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
39% less capital invested
Capital invested by funds: $138M → $84.4M (-$53.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.75M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.49M |
| 3 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$1.12M |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.07M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$684K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$3.36M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$3.32M |
| 3 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$1.56M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$1.02M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$886K |
VIGL Hedge Fund Activity: Q4 2023 in Review
46 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q4 2023, worth a combined $84.4M — down 39% from $138M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new VIGL positions and 6 closed out — a net gain of 1 holder — while 15 added to existing stakes and 12 trimmed.
The largest buyer was Sphera Funds Management, opening a new position worth an estimated $2.75M. The largest seller was Deerfield Management, cutting an estimated $3.36M.
- 46 institutional investors held Vigil Neuroscience (VIGL) as of Q4 2023, up from 45 in Q3 2023.
- Funds reported $84.4M of Vigil Neuroscience stock for Q4 2023, down 39% quarter-over-quarter.
- 7 funds opened new Vigil Neuroscience positions in Q4 2023 and 6 closed out, a net change of +1 holder.
- The largest Vigil Neuroscience buyer in Q4 2023 was Sphera Funds Management, an estimated $2.75M added.
- The largest Vigil Neuroscience seller in Q4 2023 was Deerfield Management, an estimated $3.36M sold.
Based on aggregated 13F filings for Q4 2023.